Bolt Biotherapeutics Cash Flow Statement (2019-2025) | BOLT

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -8.63M-11.06M-12.38M-16.91M-23.59M-23.39M-27.16M-23.68M-22.66M-21.76M-20.00M-16.98M-18.06M-16.26M-17.90M-15.49M-21.20M-15.18M-15.94M-11.06M-8.61M-7.23M
Depreciation and Depletion 0.10M0.10M0.20M0.20M0.30M0.20M0.30M0.40M0.40M0.40M0.40M0.50M0.50M0.40M0.50M0.50M1.80M0.40M0.50M0.40M0.40M0.30M0.30M
Share-based Compensation 0.06M0.23M0.22M0.40M0.57M2.11M2.02M2.23M2.14M2.92M2.39M2.14M2.12M2.48M2.35M2.33M2.07M2.30M2.83M1.10M1.18M0.71M0.62M0.41M
Gains from Sales and Divestitures 0.08M0.06M0.04M
Gains from Investment Securities 0.25M0.07M3.76M-0.23M10.71M0.07M6.33M0.29M
Non-cash Items 4.72M6.08M14.60M0.01M2.80M
Cash from Operations -9.64M-12.27M-12.52M-12.89M-16.56M-3.99M-18.73M-17.79M-24.31M-20.79M-13.45M-17.95M-23.40M-15.11M-16.75M-14.27M-16.75M-16.14M-13.97M-14.43M-13.37M-9.60M-9.73M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.47M0.54M0.53M0.64M0.76M-4.59M1.17M0.67M0.68M0.70M0.85M1.11M1.33M1.19M1.03M0.79M0.54M0.25M0.61M0.62M0.64M
Depreciation & Amortization (CF) 0.10M0.11M0.18M0.22M0.27M0.26M0.30M0.36M0.36M0.41M0.44M0.46M0.47M0.46M0.46M0.47M0.46M0.46M0.44M0.43M0.40M0.35M0.29M
Change in Working Capital
Change in Accured Expenses -0.54M0.10M0.22M3.10M-0.09M4.20M3.12M-0.55M-2.39M-0.69M5.57M0.29M-6.61M1.18M0.83M1.19M-3.54M0.92M0.44M-2.70M-2.51M-0.84M-1.88M
Investing Activities
Capital Expenditures 0.37M0.84M1.15M0.90M0.06M0.70M1.01M0.56M0.60M0.43M0.73M0.18M0.05M0.15M0.01M0.04M0.00M0.07M
Sales of Property, Plant and Equipment 0.15M0.96M
Change in Acquisitions & Divestments 8.05M2.60M7.61M3.80M20.82M51.28M117.53M30.91M50.10M41.98M71.88M67.25M49.13M47.98M33.26M50.23M37.35M25.48M14.58M25.26M19.68M
Cash from Investing Activities -13.61M4.41M-13.10M1.70M-190.52M-46.60M-16.11M21.03M40.84M-0.87M1.45M16.43M28.99M13.58M12.66M15.81M10.20M18.00M17.14M12.23M14.55M10.79M17.88M
Financing Activities
Other financing activities 1.82M1.14M
Change in Capital Stock
Shares Issued 0.03M0.01M0.18M0.08M244.99M-0.67M0.11M0.25M0.14M0.11M0.03M
Preferred Shares Issued -0.28M51.90M
Misc.
Cash from Financing Activities 0.03M41.55M-0.92M-1.06M297.02M13.41M0.18M0.49M0.11M0.25M0.14M0.11M0.08M0.03M0.01M
Change in Cash -23.21M33.69M-26.53M-12.25M89.94M-37.18M-34.65M3.73M16.64M-21.40M-12.00M-1.37M5.59M-1.39M-4.09M1.65M-6.55M1.94M3.17M-2.17M1.19M1.21M8.15M
Free Cash Flow -10.01M-13.11M-13.67M-13.79M-16.62M-4.69M-19.74M-18.36M-24.92M-21.22M-14.19M-18.14M-23.45M-15.11M-16.90M-14.27M-16.75M-16.18M-13.97M-14.43M-13.37M-9.60M-9.80M
Net Cash Flow -23.21M33.69M-26.53M-12.25M89.94M-37.18M-34.65M3.73M16.64M-21.40M-12.00M-1.37M5.59M-1.53M-4.09M1.65M-6.55M1.94M3.17M-2.17M1.19M1.21M8.15M